Human dendritic cell (DC)-based anti-infective therapy: Engineering DCs to secrete functional IFN-γ and IL-12

Journal of Immunology

Volumn 161, Issue 2, 1998, Pages 868-876

  Ahuja, Seema S ^a,c   Mummidi, Srinivas ^a   Malech, Harry L ^b   Ahuja, Sunil K ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c The University of Texas Health Science Center at San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12;

ANIMAL CELL; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE TRANSFER; GENETIC TRANSDUCTION; HISTOPLASMA CAPSULATUM; HUMAN; HUMAN CELL; IMMUNOTHERAPY; LEISHMANIA DONOVANI; MYCOBACTERIUM KANSASII; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE;

EID: 0032528348     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.161.2.868     Document Type: Article

References (66)

1. Mosmann, T. R., and S. Sad. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138.
2. Reiner, S. L., and R. A. Seder. 1995. T helper cell differentiation in immune response. Curr. Opin. Immunol. 7:360.
3. Trinchieri, G. 1997. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr. Opin. Immunol. 9:17.
4. Puccetti, P., L. Romani, and F. Bistoni. 1995. A TH1-TH2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol. 3:237.
5. Modlin, R. L. 1994. Th1-Th2 paradigm: insights from leprosy. J. Invest. Dermatol. 102:828.
6. Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151.
7. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
8. + cell counts have impaired Th1 responses. J. Immunol. 158:492.
9. Clerici, M., and G. M. Shearer. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15:575.
10. Badaro, R., E. Falcoff, F. S. Badaro, E. M. Carvalho, D. Pedral-Sampaio, A. Barral, I. S. Carvalho, M. Barral-Netto, M. Brandely, L. Silva, J. C. Bina, R. Teixera, R. Falcoff, H. Rocha, J. L. Ho, and W. D. Johnson. 1990. Treatment of visceral leishmaniasis with pentavalent antimony and Interferon gamma. N. Engl. J. Med. 322:16.
11. DiPiro, J. T. 1997. Cytokine networks with infection: mycobacterial infections, leishmaniasis, human immunodeficiency virus infection, and sepsis. Pharmacotherapy 17:205.
12. Steinmann, R. M. 1996. Dendritic cells and immune-based therapies. Exp. Hematol. 24:859.
13. Steinmann, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
14. Stingl, G., and P. R. Bergstresser. 1995. Dendritic cells: a major story unfolds. Immunol. Today 16:330.
15. Lotze, M. T. 1997. Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer. Ann. Surg. 226:6.
16. Mayordomo, J. I., T. Zorina, W. J. Storkus, L. Zitvogel, M. D. Garcia-Prats, A. B. DeLeo, and M. T. Lotze. 1997. Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines. Stem Cells 15:94.
17. Paglia, P., C. Chiodoni, M. Rodolfo, and M. P. Colombo. 1996. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo. J. Exp. Med. 183:317.
18. Zitvogel, L., J. I. Mayordomo, T. Tjandrawan, A. B. Deleo, M. R. Clarke, M. T. Lotze, and W. J. Storkus. 1996. Therapy of murine tumors with tumor peptide-pulsed dendritic cells:Dependence on T cells, B7 costimulation, and helper T cell-associated cytokines. J. Exp. Med. 183:87.
19. Hsu, F. J., C. Benike, F. Fagnoni, T. M. Liles, D. Czerwinski, B. Taidi, E. G. Engelman, and R. Levy. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat. Med. 2:52.
20. Inaba, K., M. Inaba, M. Naito, and R. M. Steinman. 1993. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178:479.
21. Porgador, A., and E. Gilboa. 1995. Bone marrow-generated dendritic cells pulsed with class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182:255.
22. + T cells and process soluble antigen. J. Immunol. 155:5427.
23. + lymphocytes to peptide antigen in vivo. J. Immunol. 151:6742.
24. Kupiec-Wiglinskim, J. W., J. M. Austyn, and P. J. Morris. 1988. Migration patterns of dendritic cells in the mouse: traffic from the blood, and T-cell dependent and -independent entry to lymphoid tissues. J. Exp. Med. 167:632.
25. Bujdoso, R., G. Harkiss, J. Hopkins, and I. McConnell. 1990. Afferent lymph dendritic cells: a model for antigen capture and presentation in vivo. Int. Rev. Immunol. 6:177.
26. Barratt-Boyes, S. M., S. C. Watkins, and O. J. Finn. 1997. In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model. J. Immunol. 158:4543.
27. Flamand, V., T. Sornasse, K. Thielemans, C. Demanet, M. Bakkus, H. Bazin, F. Tielemans O. Leo, J. Urbain, and M. Moser. 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24:605.
28. Trinchieri, G. 1995. Interleukin-12: a pro-inflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen specific adaptive immunity. Annu. Rev. Immunol. 13:251.
29. Romani, L., P. Puccetti, and F. Bistoni. 1997. Interleukin-12 in infectious diseases. Clin. Microbiol. Rev. 10:611.
30. Nathan, C. 1992. Interferon and inflammation. In Inflammation. J. I. Gallin, I. M. Goldstein, and R. Snyderman, eds. Raven Press, New York, p. 265.
31. Holland, S. M., E. M. Eisenstein, D. B. Kuhns, M. L. Turner, W. A. Strober, and J. I. Gallin. 1994. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon γ: a preliminary report. N. Engl. J. Med. 330: 1348.
32. Newport, M. J., C. M. Huxley, and S. Huston. 1996. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1941.
33. Frucht, D. M., and S. M. Holland. 1996. Defective monocyte costimulation for interferon-γ production in familial Mycobacterium avium complex infection: abnormal IL-12 regulation. J. Immunol. 157:411.
34. Cooper, A. M., J. Magram, J. Ferrante, and I. M. Orme. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J. Exp. Med. 186:39.
35. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon γ gene-disrupted mice. J. Exp. Med. 176:2243.
36. Carrera, L., R. T. Gazzinelli, R. Badolato, S. Hieny, W. Muller, R. Kuhn, and D. L. Sacks. 1996. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice. J. Exp. Med. 183:515.
37. + T cells. J. Exp. Med. 179:447.
38. + CTL responses in vitro. J. Clin. Invest. 98:715.
39. Seder, R. A., K. H. Grabstein, J. A. Berzofsky, and J. F. McDyer. 1995. Cytokine interactions in human immunodeficiency virus-infected individuals: roles of interleukin (IL)-2, IL-12, and IL-15. J. Exp. Med. 182:1067.
40. Clerici, M., D. R. Lucey, J. A. Berzofsky, L. A. Pinto, T. A. Wynn, S. P. Blatt, M. J. Dolan, C. W. Hendrix, S. F. Wolf, and G. M. Shearer. 1993. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262:1721.
41. Chehimi, J., S. E. Starr, I. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trinchieri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361.
42. Hilkens, C. M. U., P. Kalinski, M. Boer, and M. L. Kapsenberg. 1997. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 90: 1920.
43. Ahuja, S. S., M. R. Brown, T. A. Fleisher, S. K. Ahuja, and H. L. Malech. 1996. Autocrine activation of hemopoietic progenitor-derived myelo-monocytic cells by IFN-γ gene transfer. J. Immunol. 156:4345.
44. Melby, P. C., F. A. Neva, and D. L. Sacks. 1989. Profile of human T cell response to leishmanial antigens: analysis by immunoblotting. J. Clin. Invest. 83:1868.
45. Henderson, H. M., and G. S. Deepe, Jr. 1992. Recognition of Histoplasma capsulatum yeast-cell antigens by human lymphocytes and human T-cell clones [published erratum appears in J. Leukocyte Biol. 1992 52:133]. J. Leukocyte Biol. 51:432.
46. O'Doherty, U., M. Peng, S. Gezelter, W. J. Swiggard, M. Betjes, N. Bhardwaj, and R. M. Steinman. 1994. Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. Immunology 82:487.
47. O'Doherty, U., R. M. Steinman, M. Peng, P. U. Cameron, S. Gezelter, I. Kopeloff, W. J. Swiggard, M. Pope, and N. Bhardwaj. 1993. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J. Exp. Med. 178:1067.
48. Thomas, R., L. S. Davis, and P. E. Lipsky. 1993. Isolation and characterization of human peripheral blood dendritic cells. J. Immunol. 150:821.
49. Nijman, H. W., M. J. Kleijmeer, M. A. Ossevoort, V. M. Oorschot, M. P. Vierboom, M. Van de Keur, P. Kenemans, W. M. Kast, H. J. Geuze, and C. J. Melief. 1995. Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human dendritic cells. J. Exp. Med. 182:163.
50. + hematopoietic progenitor cells of the bone marrow and peripheral blood. Cancer Res. 55:1099.
51. Bertolini, F., D. Soligo, L. Lazzari, C. Corsini, F. Servida, and G. Sirchia. 1995. The effect of interleukin-12 in ex-vivo expansion of human haemopoietic progenitors. Br. J. Haematol. 90:935.
52. Shankar, A. H., and R. G. Titus. 1997. The influence of antigen-presenting cell type and interferon-γ on priming and cytokine secretion of Leishmania major-specific T cells. J. Infect. Dis. 175:151.
53. Verhasselt, V., C. Buelens, F. Willems, D. De Groote, N. Haeffner-Cavaillon, and M. Goldman. 1997. Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of co-stimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J. Immunol. 158:2919.
54. Kang, K., M. Kubin, K. D. Cooper, S. R. Lessin, G. Trinchieri, and A. H. Rook. 1996. IL-12 synthesis by human Langerhans cells. J. Immunol. 156:1402.
55. Henderson, R. A., S. C. Watkins, and J. L. Flynn. 1997. Activation of human dendritic cells following infection with Mycobacterium. J. Immunol. 159:635.
56. Szabolcs, P., H. F. Gallardo, D. H. Ciocon, M. Sadelain, and J. W. Young. 1997. Retrovirally transduced human dendritic cells express a normal phenotype and potent T-cell stimulatory capacity. Blood 90:2160.
57. Arthur, J. F., L. H. Butterfield, M. D. Roth, L. A. Bui, S. M. Kiertscher, R. Lau, S. Dubinett, J. Glaspy, W. H. McBride, and J. S. Economou. 1997. A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther. 4:17.
58. Moritz, T., D. C. Keller, and D. A. Williams. 1993. Human cord blood cells as targets for gene transfer: potential use in genetic therapies of severe combined immunodeficiency disease. J. Exp. Med. 178:529.
59. Henderson, R. A., M. T. Nimgaonkar, S. C. Watkins, P. D. Robbins, E. D. Ball, and O. J. Finn. 1996. Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res. 56:3763.
60. Reeves, M. E., R. E. Royal, J. S. Lam, S. A. Rosenberg, and P. Hwu. 1996. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer Res. 56:5672.
61. Aicher, A., J. Westermann, S. Cayeux, G. Willimsky, K. Daemen, T. Blankenstein, W. Uckert, B. Dorken, and A. Pezzutto. 1997. Successful retroviral mediated transduction of a reporter gene in human dendritic cells: feasibility of therapy with gene-modified antigen presenting cells. Exp. Hematol. 25: 39.
62. Manetti, R., F. Gerosa, M. G. Giudizi, R. Biagiotti, P. Parronchi, M. P. Piccinni, S. Sampognaro, E. Maggi, S. Romagnani, and G. Trinchieri. 1994. Interleukin 12 induces stable priming for interferon γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J. Exp. Med. 179:1273.
63. + T cells from alpha beta TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ-dependent. Int. Immunol. 5:1119.
64. Heinzel, F. P., R. M. Rerko, F. Hatam, and R. M. Locksley. 1993. IL-2 is necessary for the progression of leishmaniasis in susceptible murine hosts. J. Immunol. 150:3924.
65. Guler, M. L., N. G. Jacobson, U. Gubler, and K. M. Murphy. 1997. T cell genetic background determines maintenance of IL-12 signaling: effects on BALB/c and B10.D2 T helper cell type 1 phenotype development. J. Immunol. 159:1767.
66. Guler, M. L., J. D. Gorham, C. S. Hsieh, A. J. Mackey, R. G. Steen, W. F. Dietrich, and K. M. Murphy. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development. Science 271:984.